Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

ISSN： 1460-2156

Source： Brain, Vol.132, Iss.7, 2009-07, pp. : 1820-1832

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 217-228

Bentham Science Publishers

Access to resources Recommend Favorite

Immunoreactivity of Presenilin-1 and Tau in Alzheimer's Disease Brain

By Hendriks L. De Jonghe C. Lubke U. Woodrow S. Vanderhoeven I. Boons J. Cras P. Martin J.-J. Van Broeckhoven C.

Experimental Neurology, Vol. 149, Iss. 2, 1998-02 ,pp. : 341-348

Elsevier

Access to resources Recommend Favorite

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

By Obulesu M. Venu R. Somashekhar R.

Neurochemical Research, Vol. 36, Iss. 8, 2011-08 ,pp. : 1329-1335

Springer Publishing Company

Access to resources Recommend Favorite

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

By Buerger Katharina Ewers Michael Zinkowski Raymond Alafuzoff Irina Teipel Stefan J. DeBernardis John Kerkman Daniel McCulloch Cheryl Soininen Hilkka Hampel Harald

Brain, Vol. 129, Iss. 11, 2006-11 ,pp. : 3035-3041

Oxford University Press

Access to resources Recommend Favorite

Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs

By Attems Johannes Quass Magdalena Jellinger Kurt

Acta Neuropathologica, Vol. 113, Iss. 1, 2007-01 ,pp. : 53-62

Springer Publishing Company

Access to resources Recommend Favorite